Clearlink System Continu-Flo Administration Sets, Product… recallZ-0793-2020 · Baxter Healthcare Corporation · initiated Dec 12, 2019
Open, Classified
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Baxter Healthcare Corporation or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
Continu-Flo sets with male Luer bodies at the lower end of, and within, the ISO specification for outer diameter require a higher than expected connection force to fully inset and securely tighten the Luer to the ONE-LINK connector.
FDA root cause category: Device Design
What the company is doing
The firm disseminated an urgent medical device correction notice on 12/12/2019. The notice explained the issue and provided the following actions be taken: 1. Baxter will be tightening its internal specifications for the D mold to produce Luers that target the mid to upper range of the ISO specification (target date December 2019). Additional actions, as needed, will be determined through investigation. 2. If you purchased this product directly from Baxter, complete the enclosed Baxter customer reply form and return it to Baxter by faxing it to 224-270-5457 or scanning and e-mailing it to [email protected], even if you do not have any inventory. Returning the Baxter customer reply form promptly will prevent you from receiving repeat notices. 3. If you purchased this product from a distributor, please note that the Baxter customer reply form is not applicable. If a reply form is provided by your distributor or wholesaler, please return it to the supplier according to their instructions. 4. If you distribute this product to other facilities or departments within your institution, please forward a copy of this communication to them. 5. If you are a dealer, wholesaler, distributor/reseller, or original equipment manufacturer (OEM) that distributed any affected product to other facilities, please distribute this notification to customers and check the associated box on the reply form. For general questions regarding this communication, contact Baxter Product Surveillance at 800-437-5176, between the hours of 8:00 am and 5:00 pm Central Time, Monday through Friday.
Recall details
- Recall number
- Z-0793-2020
- Status
- Open, Classified
- Initiated by the company
- Dec 12, 2019
- Recalling firm
- Baxter Healthcare Corporation
- Quantity
- 271,014,984 units
- Product code
- FPA
- FDA submissions
- K961225
- Distribution
- Worldwide distribution - US Nationwide distribution and countries of Bermuda, Bahamas, Trinidad and Tobago, Grand Cayman, St. Thomas, Guyana and Barbados, Mexico, Canada, and New Zealand.
Product description
Clearlink System Continu-Flo Administration Sets, Product Codes: 2C8519, 2C8537, and 2C8541 - Product Usage:For the administration of fluids from a container into the patients vascular system through a vascular access device.
Code information (models, lots, serial numbers)
Product Codes: 2C8519, UDI 00085412048994; 2C8537, UDI 00085412048970; and 2C8541, UDI 00085412071107 All Lots
Devices named in this recall
3 devices in the FDA device registry whose identifier appears in the recall's code information.
- CLEARLINK/CONTINU-FLO/DUO-VENT 2C8541Baxter Healthcare Corporation · Set, administration, intravascular2 recalls797 reports
- CLEARLINK/CONTINU-FLO 2C8537Baxter International Inc. · Set, administration, intravascular2 recalls490 reports
- CLEARLINK/CONTINU-FLO 2C8519Baxter Healthcare Corporation · Set, administration, intravascular3 recalls1 death221 reports
Product lines
Other devices under the same FDA submission
21 devices cleared under K961225 are not named by identifier in this recall. One submission often covers many models, so they may or may not be affected.
- CLEARLINK/CONTINU-FLO 2R8537Baxter International Inc. · Set, administration, intravascular1 recall136 reports
- CLEARLINK/CONTINU-FLO/DUO-VENT UC8519Baxter International Inc. · Set, administration, intravascular1 recall66 reports
- CLEARLINK/CONTINU-FLO 2H8519Baxter Healthcare Corporation · Set, administration, intravascular93 reports
- CLEARLINK/CONTINU-FLO 2R8519Baxter International Inc. · Set, administration, intravascular1 recall37 reports
- CLEARLINK/CONTINU-FLO 2R8546Baxter International Inc. · Set, administration, intravascular59 reports
- CLEARLINK/DUO-VENT 2C7462Baxter Healthcare Corporation · Set, administration, intravascular57 reports
- DUO-VENT 1C8507Baxter Healthcare Corporation · Set, administration, intravascular1 recall4 reports
- CLEARLINK 2C7461Baxter Healthcare Corporation · Set, administration, intravascular49 reports
- CLEARLINK/DUO-VENT 2H7462Baxter International Inc. · Set, administration, intravascular47 reports
- NA 1C8109Baxter Healthcare Corporation · Set, administration, intravascular32 reports
- CLEARLINK/CONTINU-FLO 2H8537Baxter Healthcare Corporation · Set, administration, intravascular24 reports
- CLEARLINK/CONTINU-FLO 2C8546Baxter Healthcare Corporation · Set, administration, intravascular22 reports
Other products in the same recall event
The FDA groups related products into one recall event (event 84511).
- Z-0794-2020 · Open, ClassifiedONE-LINK Needle-free IV Connector, Product Codes: 7N8300, 7N8301, 7N8310, 7N8330K, 7N8332K, 7N8334K, 7N8370K, 7N8371, 7N8375K, 7N8376K, 7N8377, 7N8378, 7N8390, 7N8391, 7N8399 - Pro…
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 16, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page